Search Results - "Heston, Warren"

Refine Results
  1. 1

    A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies by O'Keefe, Denise S, Bacich, Dean J, Huang, Steve S, Heston, Warren D W

    Published in Journal of Nuclear Medicine (01-07-2018)
    “…In this review, we cover the evolution of knowledge on the biology of prostate-specific membrane antigen (PSMA) and its translation to therapy. The usual key…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    PARP inhibition sensitizes to low dose-rate radiation TMPRSS2-ERG fusion gene-expressing and PTEN-deficient prostate cancer cells by Chatterjee, Payel, Choudhary, Gaurav S, Sharma, Arishya, Singh, Kamini, Heston, Warren D, Ciezki, Jay, Klein, Eric A, Almasan, Alexandru

    Published in PloS one (02-04-2013)
    “…Exposure to genotoxic agents, such as irradiation produces DNA damage, the toxicity of which is augmented when the DNA repair is impaired. Poly (ADP-ribose)…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Development of targeted near-infrared imaging agents for prostate cancer by Wang, Xinning, Huang, Steve S, Heston, Warren D W, Guo, Hong, Wang, Bing-Cheng, Basilion, James P

    Published in Molecular cancer therapeutics (01-11-2014)
    “…Prostate cancer is the most common noncutaneous malignancy affecting men in North America. Radical prostatectomy remains a definitive treatment for prostate…”
    Get full text
    Journal Article
  7. 7

    Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer by Ghosh, Arundhati, Heston, Warren D.W.

    Published in Journal of cellular biochemistry (15-02-2004)
    “…Prostate specific membrane antigen (PSMA), is a unique membrane bound glycoprotein, which is overexpressed manifold on prostate cancer as well as…”
    Get full text
    Journal Article
  8. 8

    Targeted, Activatable, In Vivo Fluorescence Imaging of Prostate-Specific Membrane Antigen (PSMA) Positive Tumors Using the Quenched Humanized J591 Antibody–Indocyanine Green (ICG) Conjugate by Nakajima, Takahito, Mitsunaga, Makoto, Bander, Neil H, Heston, Warren D, Choyke, Peter L, Kobayashi, Hisataka

    Published in Bioconjugate chemistry (17-08-2011)
    “…In patients with prostate cancer, a positive surgical margin is associated with an increased risk of cancer recurrence and poorer outcome, yet margin status…”
    Get full text
    Journal Article
  9. 9

    In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen by Wang, Xinning, Ma, Dangshe, Olson, William C, Heston, Warren D W

    Published in Molecular cancer therapeutics (01-09-2011)
    “…Prostate-specific membrane antigen (PSMA) is a membrane protein that is overexpressed manifold in prostate cancer and provides an attractive target for…”
    Get full text
    Journal Article
  10. 10

    Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression by Yin, Lihong, Rao, Pravin, Elson, Paul, Wang, Jianghua, Ittmann, Michael, Heston, Warren D W

    Published in PloS one (24-06-2011)
    “…Prostate specific membrane antigen (PSMA) is overexpressed in prostatic adenocarcinoma (CaP), and its expression is negatively regulated by androgen…”
    Get full text
    Journal Article
  11. 11

    Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness by GHOSH, Arundhati, XINNING WANG, KLEIN, Eric, HESTON, Warren D. W

    Published in Cancer research (Chicago, Ill.) (01-02-2005)
    “…Prostate-specific membrane antigen (PSMA), a type II transmembrane glycoprotein, is overexpressed in prostate cancer. PSMA is a unique cell surface marker,…”
    Get full text
    Journal Article
  12. 12

    Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin) by Singh, Kamini, Sharma, Arishya, Mir, Maria C, Drazba, Judith A, Heston, Warren D, Magi-Galluzzi, Cristina, Hansel, Donna, Rubin, Brian P, Klein, Eric A, Almasan, Alexandru

    Published in Molecular cancer (23-03-2014)
    “…Macroautophagy is a catabolic process that can mediate cell death or survival. Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand…”
    Get full text
    Journal Article
  13. 13

    Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines by Wang, Yu, Romigh, Todd, He, Xin, Orloff, Mohammed S., Silverman, Robert H., Heston, Warren D., Eng, Charis

    Published in Human molecular genetics (15-11-2010)
    “…The tumor suppressor gene PTEN (phosphatase and tensin homolog deleted on chromosome 10) and the androgen receptor (AR) play important roles in tumor…”
    Get full text
    Journal Article
  14. 14

    Should Low Molecular Weight PSMA Targeted Ligands Get Bigger and Use Albumin Ligands for PSMA Targeting? by Huang, Steve S, Heston, Warren D W

    Published in Theranostics (01-01-2017)
    “…Prostate Specific Membrane Antigen (PSMA) is strongly expressed in prostate cancer. Recently a number of low-molecular-weight inhibitors have demonstrated…”
    Get full text
    Journal Article
  15. 15

    Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker by Huang, Steve S., Wang, Xinning, Zhang, Yuqing, Doke, Aniruddha, DiFilippo, Frank P., Heston, Warren D.

    Published in The Prostate (01-05-2014)
    “…BACKGROUND Prostate specific membrane antigen (PSMA) is overexpressed in prostate cancer and in tumor vasculature. Small molecule based inhibitors of PSMA have…”
    Get full text
    Journal Article
  16. 16

    A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [68Ga]Ga-PSMA-11 by Huang, Steve S., DiFilippo, Frank P., Lindner, Daniel J., Heston, Warren D.

    Published in EJNMMI radiopharmacy and chemistry (30-01-2024)
    “…Background The current generation of radiolabeled PSMA-targeting therapeutic agents is limited by prominent salivary gland binding, which results in…”
    Get full text
    Journal Article
  17. 17

    The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition by Chatterjee, Payel, Choudhary, Gaurav S, Alswillah, Turkeyah, Xiong, Xiahui, Heston, Warren D, Magi-Galluzzi, Cristina, Zhang, Junran, Klein, Eric A, Almasan, Alexandru

    Published in Molecular cancer therapeutics (01-08-2015)
    “…Exposure to genotoxic agents, such as ionizing radiation (IR), produces DNA damage, leading to DNA double-strand breaks (DSB); IR toxicity is augmented when…”
    Get full text
    Journal Article
  18. 18

    Moderate expression of prostate-specific membrane antigen, a tissue differentiation antigen and folate hydrolase, facilitates prostate carcinogenesis by Yao, Veronica, Parwani, Anil, Maier, Christoph, Heston, Warren DeWayne, Bacich, Dean John

    Published in Cancer research (Chicago, Ill.) (01-11-2008)
    “…Increased expression of PSMA, a differentiation antigen with folate hydrolase activity, is an independent marker of prostate cancer progression. Mice…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Selenoprotein P neutralizes lipopolysaccharide and participates in hepatic cell endoplasmic reticulum stress response by Zhao, Yongzhong, Banerjee, Shuvojit, Huang, Ping, Wang, Xinning, Gladson, Candece L., Heston, Warren D., Foster, Charles B.

    Published in FEBS letters (01-12-2016)
    “…Low serum selenium or selenoprotein P (SePP) levels have been repetitively observed in severe sepsis. The role of SePP in sepsis is incompletely characterized…”
    Get full text
    Journal Article